Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Adaptive designs with arbitrary dependence structure.

Schmidt R, Faldum A, Witt O, Gerss J.

Biom J. 2014 Jan;56(1):86-106. doi: 10.1002/bimj.201200234. Epub 2013 Nov 11.

PMID:
24395207
2.

Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.

Graf AC, Bauer P, Glimm E, Koenig F.

Biom J. 2014 Jul;56(4):614-30. doi: 10.1002/bimj.201300153. Epub 2014 Apr 22.

3.

Two-stage adaptive designs with correlated test statistics.

Hommel G, Lindig V, Faldum A.

J Biopharm Stat. 2005;15(4):613-23.

PMID:
16022167
4.

Adaptive designs with correlated test statistics.

Götte H, Hommel G, Faldum A.

Stat Med. 2009 May 1;28(10):1429-44. doi: 10.1002/sim.3555.

PMID:
19226563
5.

On efficient two-stage adaptive designs for clinical trials with sample size adjustment.

Liu Q, Li G, Anderson KM, Lim P.

J Biopharm Stat. 2012;22(4):617-40. doi: 10.1080/10543406.2012.678226.

PMID:
22651105
6.
7.
8.

Evaluation of experiments with adaptive interim analyses.

Bauer P, Köhne K.

Biometrics. 1994 Dec;50(4):1029-41.

PMID:
7786985
9.

Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.

Brannath W, Bretz F, Maurer W, Sarkar S.

Biom J. 2009 Dec;51(6):885-98. doi: 10.1002/bimj.200900132.

PMID:
20014203
10.

Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.

Boessen R, van der Baan F, Groenwold R, Egberts A, Klungel O, Grobbee D, Knol M, Roes K.

Pharm Stat. 2013 Nov-Dec;12(6):366-74. doi: 10.1002/pst.1599. Epub 2013 Sep 23.

PMID:
24214896
11.

Adaptive trial design: a general methodology for censored time to event data.

Jahn-Eimermacher A, Ingel K.

Contemp Clin Trials. 2009 Mar;30(2):171-7. doi: 10.1016/j.cct.2008.12.002. Epub 2008 Dec 16.

PMID:
19130902
12.

Interim analysis and sample size reassessment.

Posch M, Bauer P.

Biometrics. 2000 Dec;56(4):1170-6.

PMID:
11129475
13.

On sample size and inference for two-stage adaptive designs.

Liu Q, Chi GY.

Biometrics. 2001 Mar;57(1):172-7.

PMID:
11252594
14.

Estimation in flexible two stage designs.

Brannath W, König F, Bauer P.

Stat Med. 2006 Oct 15;25(19):3366-81.

PMID:
16220489
15.

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.

Posch M, Maurer W, Bretz F.

Pharm Stat. 2011 Mar-Apr;10(2):96-104. doi: 10.1002/pst.413.

PMID:
22328314
16.

Adaptive design clinical trials and trial logistics models in CNS drug development.

Wang SJ, Hung HM, O'Neill R.

Eur Neuropsychopharmacol. 2011 Feb;21(2):159-66. doi: 10.1016/j.euroneuro.2010.09.003. Epub 2010 Oct 8. Review.

PMID:
20933373
17.

Familywise error control in multi-armed response-adaptive two-stage designs.

Gutjahr G, Posch M, Brannath W.

J Biopharm Stat. 2011 Jul;21(4):818-30. doi: 10.1080/10543406.2011.551337.

PMID:
21516571
18.

The advantages and disadvantages of adaptive designs for clinical trials.

Bauer P, Brannath W.

Drug Discov Today. 2004 Apr 15;9(8):351-7. Review.

PMID:
15081962
19.

Benefits, challenges and obstacles of adaptive clinical trial designs.

Chow SC, Corey R.

Orphanet J Rare Dis. 2011 Nov 30;6:79. doi: 10.1186/1750-1172-6-79.

Supplemental Content

Support Center